NCT02284971View on ClinicalTrials.gov

Pilot Study of SBRT and CDX-1127 in Prostate Cancer

PHASE1TerminatedINTERVENTIONAL

Enrollment

2

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

April 7, 2016

Study Completion Date

April 7, 2016

Conditions

Prostatic NeoplasmsProstate Cancer

Interventions

BIOLOGICAL

CDX1127

RADIATION

SBRT

Trial Locations (1)

22908

University of Virginia, Charlottesville

Sponsors

Collaborators (1)

Celldex Therapeutics

All Listed Sponsors

collaborator

Celldex Therapeutics

INDUSTRY

lead

James Larner, MD

OTHER

NCT02284971 - Pilot Study of SBRT and CDX-1127 in Prostate Cancer | Biotech Hunter | Biotech Hunter